Introduction
The granulocyte colony-stimulating factor receptor (G-CSF-R) is the major cytokine receptor involved in neutrophil development (Demetri and Griffin, 1991; Avalos, 1996; . G-CSF-R activates multiple signaling molecules that control the proliferation and survival of myeloid precursors. In myeloid cell line models such as 32D, G-CSF-R induces proliferation in the first 4-6 days of culture, followed by growth arrest and terminal granulocytic differentiation (Dong et al., 1993; Fukunaga et al., 1993) . How this balance is maintained is largely unknown. Truncated G-CSF-R resulting from nonsense mutations in CSFR3 are found in B20% of patients with severe congenital neutropenia (SCN). These mutations are linked with progression of SCN to acute myeloid leukemia (AML) . The truncated G-CSF-Rs confer a hyperproliferative response to G-CSF in knockin mouse models and are unable to transduce differentiation signals in 32D cells (Dong et al., 1998; McLemore et al., 1998; Hermans et al., 1999; Ward et al., 1999b; Aarts et al., 2004) . These mutants are defective in internalization, supporting the importance of a tight control of G-CSF-R membrane expression for a balanced signaling output (Hunter and Avalos, 1999; Ward et al., 1999b; Aarts et al., 2004) . Although ligandinduced receptor endocytosis is a major mechanism for signal attenuation, less is known of mechanisms that control steady-state expression of cytokine receptors on the plasma membrane and their contribution to signaling.
We recently identified the gene encoding WD40 repeat and suppressor of cytokine signaling (SOCS) boxcontaining protein 2 (Wsb-2) in a retroviral screen for leukemia genes . Wsb-1-2 proteins share 46% homology and belong to a protein family characterized by a SOCS box (SB) (Hilton et al., 1998) . Together with elongin B/C and cullin-2 or 5, these proteins form elongin-cullin-SOCS protein (ECS) complexes, which function as E3 ubiquitin (Ub) ligases and in which the SOCS box proteins are thought to bind the substrates that are targeted for ubiquitylation (Kamura et al., 1998 (Kamura et al., , 2004 . This was recently demonstrated for ASB-2, an SB protein involved in myeloid differentiation and for WSB-1, implicated in thyroid hormone activation (Dentice et al., 2005; Heuze et al., 2005) . Substrate specificities of ECS complexes are still largely unknown. Moreover, it is unclear whether SB proteins predominantly participate in polyubiquitylation and proteasomal degradation or also in lysosomal routing involving mono-or multiubiquitylation of substrates (Schnell and Hicke, 2003) .
Here, we show that Wsb-2 (and the homologous Wsb-1) binds to the distal 13 amino acids of G-CSF-R. In myeloid 32D cells, mutants lacking this region confer a hyperproliferative response, associated with reduced granulocytic differentiation. Wsb affects cell surface expression of G-CSF-R via a mechanism depending on the conserved lysine residues in the G-CSF-R and on the Wsb SB, implicated in ubiquitylation of target substrates. All integrations in Wsb-2 identified in the retroviral screen disrupted the gene structure, suggesting that Wsb-2 may act as a tumor suppressor or as a haploinsufficient gene. WSB-2 expression was also reduced in a subclass of AML patients. Based on these findings, we propose a model in which Wsb-2 induces ubiquitylation of the G-CSF-R, thereby controlling steady-state surface expression levels. This control appears essential for the appropriate balance of G-CSF-induced proliferation and differentiation, and may be lost in cases of murine and human AML.
Results
Wsb binds to the COOH terminus of G-CSF-R in Yeast two-hybrid and co-immunoprecipitation assays and colocalizes with G-CSF-R in intact cells Previous studies indicated that the carboxyl terminal (C-terminal) part of the G-CSF-R is crucial for G-CSFinduced granulocytic differentiation (Dong et al., 1993; Fukunaga et al., 1993) . Yeast two-hybrid (Y2H) analysis was performed to identify proteins that interact with this region. Using G-CSF-R762-813 as bait, candidate interacting proteins were identified, including the WD40 repeat domain proteins Fizzy-related 1 (FzR1), Wsb-1 and Wsb-2 (Figure 1, upper panel) . Deletion of the SB domain (DSB) did not affect Wsb-1/2 binding to the G-CSF-R bait (Figure 1, upper panel) . Wsb proteins failed to interact with G-CSF-R762-790, indicating that the distal 23 amino acids of G-CSF-R are crucial for binding (Figure 1, lower panel) . In COS cells, FLAG-tagged Wsb-1 and Wsb-2 co-immunoprecipitated with G-CSF-R in hemagglutinin-immunoprecipitation (HA-IP)'s, as did the WD40 domain of FzR1 (Figure 2a) . No interactions were seen with an irrelevant control protein SV40 large T (SVT) or with empty vector controls (Figure 2a) . Similar results were obtained in the reverse FLAG IP/HA Western experiments (Figure 2b ). No interactions were observed between G-CSF-RD715 and Wsb-1, Wsb-2 or FzR-WD40 (Figure 2c and d) . Confocal laser scanning microscopy (CLSM) showed that Wsb-2 colocalized with WT-G-CSF-R in transfected human epidermal keratinocytes (HEK)293 T cells (Figure 3a) , but not with G-CSF-RD715 or G-CSF-RD769, mutants that lack the WD40-interacting distal 23 amino acids ( Figure  3b and c) . Conversely, G-CSF-RD749-769, a mutant defective in internalization but retaining its distal region, again colocalized with Wsb in intracellular vesicles (Figure 3d ).
G-CSF-R/Wsb interactions in mammalian protein-protein interaction trap assay
To establish that Wsb and G-CSF-R proteins interact in living mammalian cells in the correct subcellular context, we performed mammalian protein-protein interaction trap (MAPPIT), a cytokine receptor-based two-hybrid assay (Eyckerman et al., 2001) . Intracellular fragments of G-CSF-R were coupled to the C terminus of the erythropoietin (EPO)/leptin receptor hybrid bait (Figure 4a ) (Tavernier et al., 2002) . First, we validated the MAPPIT system for G-CSF-R-containing baits using preys containing full-length Shc or Grb2, proteins that bind directly to phosphorylated Y764 of G-CSF-R (Ward et al., 1999a) . As predicted, Shc and Grb2 interacted efficiently with bait C65, but not with C65-Y764F (Figure 4b ). Wsb-1 and Wsb-2 strongly interacted with C65, whereas no binding with the control bait (EPO-R) was observed (Figure 4c ). These results show that Wsb specifically binds to the G-CSF-R and not to the leptin receptor backbone of the bait. FzR1 did not bind to the G-CSF-R bait (data not shown), indicating that Wsb, but not FzR1 may control G-CSF-R function. Removal of the SB did not affect Wsb binding to C65. Wsb binding to C65D803 was strongly reduced and no longer detected with C65D792 ( Figure 4d ). These results corroborate the Y2H, immunoprecipitation and CLSM experiments and establish that Wsb binding specifically occurs to the C-terminal 10-20 amino acids of the G-CSF-R.
Wsb-binding region of G-CSF-R influences steady-state expression levels and controls the balance between proliferation and differentiation signals
To study the role of Wsb-binding amino acids in G-CSF-R distribution and function, we generated multiple independent clones of 32Dcl10 cells expressing a C-terminal deletion mutant lacking the 13 C-terminal amino acids (G-CSF-RD800). Steady-state membrane expression of G-CSF-RD800 was consistently increased compared to WT G-CSF-R (Figure 5a ). Contrary to G-CSF-RD715, ligand-induced internalization of G-CSF-RD800 in 32D cells was normal and occurred with similar kinetics as internalization of WT G-CSF-R (Figure 5b ), indicating that increased expression levels were not due to defective endocytosis. The rate of proliferation of 32D/G-CSF-RD800 cells in G-CSFcontaining cultures was significantly increased compared to 32D/G-CSF-R-WT and matched growth rates of 32D/G-CSF-RD715 in the first days of culture ( Figure 5c ). This was accompanied by a lack of terminal neutrophilic differentiation (Figure 5d ), indicating a major role of the C-distal 13 amino acids of G-CSF-R in controlling the proliferation/differentiation balance in response to G-CSF.
Wsb fusion reduces steady-state G-CSF-R expression on the plasma membrane Next, we determined the effects of Wsb on G-CSF-R distribution. Unfortunately, we could not generate 32D clones stably expressing Wsb-1 or Wsb-2, possibly because WD40 repeats bind to substrates that are crucial for cell growth (Smith et al., 1999; Neer and Smith, 2000) . To overcome this problem, we generated constructs with Wsb-1 or Wsb-2 fused to G-CSF-R mutant D769 via a flexible linker (GGS) (Figure 6a ). Although membrane expression of G-CSF-RD769 was consistently higher than that of WT G-CSF-R, fusion of Wsb-2 to G-CSF-RD769 significantly reduced membrane expression levels, an effect that depended on the SB (Figure 6b ). Similar results were obtained with G-CSF-RD769-Wsb1 fusions (data not shown). Replacement of the five conserved lysines in the G-CSF-R moiety of G-CSF-RD769-Wsb2 by arginines Figure 2 Co-immunoprecipitation of Wsb-1 and Wsb-2 with G-CSF-R. COS cells were transfected with pSG5-HA-G-CSF-R, pSG5-HA-D715 or pSG5-empty vector in combination with pMT2-FLAG-Wsb1, pMT2-FLAG-Wsb-2, pMT2-FLAG-FzRWD40 (positive control) or pMT2-FLAG-SVT (negative control). After 48 h, cells were lysed and proteins immunoprecipitated with antibodies against HA-tagged G-CSF-R (a and c) or FLAG-tagged Wsb and control proteins (b and d). Blots were restained with anti-FLAG and anti-HA (Santa Cruz Biotechnology, CA, USA) as indicated. Arrows mark positions of co-precipitated products (upper panels) and input of precipitates (lower panels). W1,W2: Wsb1,Wsb2; EV: empty vector; SVT: SV40 large T.
Wsb-2 controls G-CSF receptor routing SJ Erkeland et al (K5R-G-CSF-RD769-Wsb2) reverted membrane expression to normal levels, suggesting a role of ubiquitylation of receptor lysines in steady-state distribution of G-CSF-R (Figure 6c ). Indeed, we could demonstrate ubiquitylation of lysines in WT-G-CSF-R (Figure 6d , upper panel). The size distribution of Ub-G-CSF-R species was suggestive of mono-or multi-instead of polyubiquitylation, which is in agreement with the lack of reactivity with FK2, a monoclonal antibody (mAb) with high affinity for poly-Ub (Figure 6d , middle panel) (Haglund et al., 2003) . Staining for G-CSF-R showed significantly higher protein levels of K5R compared with WT G-CSF-R (Figure 6d , lower panel), suggesting that the receptor lysines are crucial for protein degradation. G-CSF-RD769-Wsb2 predominantly accumulated in the endoplasmic reticulum and intracellular vesicles, whereas G-CSF-RD769-Wsb2DSB and K5R-G-CSF-RD769-Wsb2 were both mainly found on the cell membrane ( Figure 6e ). In agreement with this, G-CSFinduced phosphorylation of STAT3, STAT5, Erk, p38 MAPK ( Figure 7a ) and Janus-activated kinase (JAK)2 (Figure 7b ) in G-CSF-RD769-Wsb1/2-expressing cells was strongly diminished compared to G-CSF-R D769.
This inhibitory effect of Wsb again depended on the presence of the SB. Electrophoretic mobility shift assay (EMSA) analysis of activated STAT3 and STAT5 as well as long-term suspension cultures gave similar results and confirmed that the lysines in G-CSF-R are crucial for the inhibitory effects of Wsb (Figure 7c and d) .
Involvement of Wsb-2 in AML Previously, we identified Wsb-2 in a common virus integration site in a murine myeloid leukemia model . Locus-specific polymerase chain reaction (PCR) (Figure 8a) showed that the five integrations in Wsb-2 identified in independent leukemia samples occurred between exons 4 and 7, leading to disruption of the gene (Figure 8b) . Because of the nonclonal nature of Murine Leukemia Virus (MuLV)-induced tumors , we were unable to verify the status of the other allele or to determine Wsb-2 expression levels in single leukemic clones. As an alternative, we examined WSB-2 expression in human AML, using gene expression profiling data set of 285 AML cases (Valk et al., 2004) . 
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Significance analysis of microarrays (Tusher et al., 2001) revealed that WSB-2 expression is significantly decreased (fold change ¼ 0.45152, score ¼ À6.33656, q-value ¼ 0.109866108) in a subclass of patients (cluster 4), characterized by mutations in CEBPA (Valk et al., 2004) . These data were confirmed by quantitative reverse transcriptase-PCR (not shown) and suggest that reduced WSB-2 levels may play a role in perturbed G-CSF responses in this group of AML patients.
Discussion
The key observations reported here are that (i) Wsb proteins bind to the G-CSF-R C terminus and thereby modulate plasma membrane levels of G-CSF-R, (ii) removal of the Wsb-binding domain increases the proliferation signaling abilities of G-CSF-R at the expense of its ability to induce differentiation and (iii) lysines in the G-CSF-R and the E3 ligase-recruiting SB of Wsb are both necessary for G-CSF-R distribution and signaling function, suggesting that Wsb acts via ubiquitylation of the G-CSF-R. Given that one Ub moiety increases the molecular size of a protein with B8 kDa, it appears that G-CSF-R is mainly mono-or multiubiquitylated. Whereas polyubiquitylation serves as a signal for proteasome-mediated protein degradation, mono-Ubs act as a sorting signals for delivery of proteins in the biosynthetic or endocytic pathway to multivesicular bodies and lysosomes (Aguilar and Wendland, 2003; Hicke and Dunn, 2003) . Direct or indirect association with E3 ligases regulates cell surface expression of a number of receptors. 
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For instance, for the degradation of the interferon a receptor 1 (IFNAR1), a mechanism was proposed involving the Homolog of Slimb (HOS) F-box protein, which interacts with Skp1 and cullin-1 to form the SCF HOS E3 complex (Kumar et al., 2003 (Kumar et al., , 2004 . Similar to Wsb, HOS (alternatively termed b-TrCP2 or Fbw1b) binds to substrates via its WD40 domain. Lysine residues in the cytoplasmic tail that are ubiquitylated by SCF HOS are essential for IFNAR1 degradation (Kumar et al., 2003) . However, a major difference is that binding of Wsb to G-CSF-R does not require receptor activation. This supports the notion that Wsb proteins are dispensable for ligand-induced internalization, but mainly affect the steady-state membrane expression of G-CSF-R by targeting excess protein for lysosomal degradation. A similar role has recently been proposed for SOCS5 in the control of the steady-state distribution of the epidermal growth factor receptor (Kario et al., 2005) .
To study the consequences of reduced Wsb levels on G-CSF-R distribution, we have attempted to knockdown Wsb-1 and Wsb-2 expression using small interfering (si) RNA. However, although significant reduction of Wsb transcript levels in HEK293 and 32D cells was achieved, siRNAs were found to nonspecifically reduce G-CSF-R expression on the cell membrane. Recent studies have revealed that siRNAs cause the activation of Toll-like receptors and induce strong IFN responses in cells, which might explain these nonspecific effects (Reynolds et al., 2006) . Because Wsb-1 and Wsb-2 (double) knockout mice are not yet available, the question whether Wsb-1 and Wsb-2 have unique or (partly) redundant functions in G-CSF-R routing and signaling cannot be addressed at present.
Wsb fusion to the G-CSF-R resulted in more prominent effects than the presence of the G-CSF-R region involved in Wsb binding, both on receptor routing (compare Figures 6d and 3a, left panel) and on signaling (Figure 7) . The reason for this is unclear but likely relates to temporal and stoichiometric aspects of the protein-protein interaction that are overridden by the fusion. Nonetheless, the results are compatible with a role of the receptor C-terminus in recruiting E3 ligase activity that ubiquitylates one or more of the conserved lysine residues in the G-CSF-R, thereby controlling its steady-state membrane expression as well as overall protein stability. Previous studies showed that SOCS3 acts in a negative feedback loop, involving G-CSFinduced activation of STAT3, STAT3-induced transcription of SOCS3 and binding of SOCS3 protein to phosphorylated Y729 of G-CSF-R (Hermans, 2003 no. 17; Hortner, 2002, no. 25; van de Geijn, 2004, no. 26) . In contrast, Wsb-1 and Wsb2 transcript levels were high in non-stimulated 32D cells and primary bone marrow progenitors and not altered by G-CSF (data not shown). Although SOCS3 attenuates G-CSF signaling from activated receptors, Wsb appears to control steady-state lysosomal degradation as well as the levels of G-CSF-R expressed on the cell membrane, thereby contributing upfront to a balanced response of myeloid precursors to G-CSF. The observation that disruption of the Wsb-2 gene (mouse leukemia) and truncation of the G-CSF-R C-terminus (SCN/AML patients) are both associated with AML supports the notion that disruption of the control of steady-state expression of G-CSF-R leads to perturbed myeloid differentiation in vivo and may contribute to leukemic outgrowth.
Materials and methods

PCR primers
Primers are listed in Supplementary Table 1. Y2H analysis Y2H was performed using yeast strain PJ69-4A (Dr Philip James, University of Wisconsin, Madison, WI, USA) as described (James et al., 1996; van Zon et al., 2002) . As prey library, a mouse 17-day embryo cDNA library (Matchmaker, Clontech Laboratories, Palo Alto, CA, USA) was used. For a second screen, cDNA library plasmids were co-transformed with the pGBT9-GCSFR762-813 or pGBT9-GCSFR762-790 bait. Prey inserts from this second selection were nucleotide sequenced (ABI 3100, Applied Biosystems, Weiterstadt, Germany). Constructs used are described in Supplementary Materials and methods.
Immunoprecipitation and Western blotting COS cells were transfected with pSG5-HA-G-CSF-R together with pMG2-WSB-1, pMG2-WSB-2, pMG2-FzR-WD40 or pMG2-SVT (Eyckerman et al., 2001 . After 48 h, cell lysates were incubated with anti-FLAG (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) or anti-HA (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. Immunecomplexes were visualized by Western blotting as described (Dong et al., 2001) . HEK293 cells were transfected with the different G-CSF-R mutants. After 48 h, cell lysates were either incubated with anti-Jak-2 antibodies (Bio Connect, Veenendaal, The Netherlands) or analysed by Western blotting using phosphorylation-specific antibodies against Stat5 (Becton Dickinson, Alphen a/d Rijn, The Netherlands), Stat3 Wsb-2 controls G-CSF receptor routing SJ Erkeland et al (Westburg, Leusden, The Netherlands), p38 (Westburg) and Erk (Tebu-Bio, Heerhugowaard, The Netherlands) and against total Erk for loading control (Campro, Veenendaal, The Netherlands). Phosphorylated Jak-2 and total Jak-2 input were visualized by Western blotting using anti-phosphotyrosine (PY99) and anti-Jak2 antibodies (Tebu-bio), respectively. Constructs used are described in Supplementary Materials and methods.
Immunofluorescence microscopy HEK293 cells were transfected with enhanced green fluorescent protein-fusion constructs of WT G-CSF-R, G-CSF-RD715, G-CSF-RD769 or G-CSF-RD749-769 in pBabe together with pMT2-MYC-WSB (see Supplementary Materials and methods). Cells were fixed and stained using mouse anti-MYC monoclonal antibodies (9E10, Santa Cruz Biotechnology, CA, USA) and tetramethyl rhodamine isothiocynate-conjugated goat-anti-mouse secondary antibodies as described . To examine subcellular localization of the fluorescent proteins, CLSM was performed on a Zeiss LSM510 (Carl Zeiss BV, Sliedrecht, The Netherlands).
MAPPIT MAPPIT was performed as described . For details and constructs see supplementary M&M.
Retroviral gene transfer in 32D cells
IL-3-dependent murine myeloid 32D cells were infected with the different Babe-based retroviral vectors and selected on 1 mg/ml puromycin (Sigma, Zwijndrecht, The Netherlands) as described . Retroviral vectors are described in Supplementary Materials and methods.
Flow cytometric analysis of G-CSF-R expression and internalization in transduced 32D cells To determine G-CSF-R expression, transduced 32D cells were labeled with biotinylated antihuman antibody recognizing an N-terminal extracellular epitope of the G-CSF-R (LMM741; Pharmingen, San Diego, CA, USA), subsequently incubated with phycoerythrin-conjugated streptavidin (SA-PE; DAKO Diagnostics, Glostrup, Denmark) and analysed by flow cytometry using a FACScan (Becton Dickinson, Sunnyvale, CA, USA) as described . Ligand-induced internalization was assessed at several time points after G-CSF treatment as described .
STAT3 and STAT5 electrophoretic mobility shift assay EMSA to detect activated STAT3 and STAT5 complexes in nuclear extracts of 32D cell transfectants were performed as described (de Koning et al., 2000) . Figure 7 Effects of Wsb on G-CSF-induced STAT activation and proliferation. 32D clones transduced with indicated G-CSF-R constructs were serum deprived for 4 h and then incubated with ( þ ) or without (À) 100 ng/ml G-CSF for 10 min at 371C. (a) Cell lysates analysed by Western blotting using phosphorylation-specific antibodies against Stat5, Stat3, p38 and Erk and against total Erk (loading control). (b) Anti-Jak-2 immunoprecipitation; blots were stained with anti-phospho-tyrosine and anti-Jak2 as indicated. (c) STAT3 and STAT5 EMSA; nuclear extracts were prepared and assayed by EMSA using STAT5-and STAT3-specific radiolabeled probes as described in Materials and methods. Results of one out of three representative clones per construct are shown. 
G-CSF-R ubiquitylation
Phoenix E cells (G. Nolan, Stanford, CA, USA) were transfected with HA-tagged wild type (wt) or mutant-G-CSF-R and FLAG-tagged Ub using the calcium-phosphate precipitation method. After 48 h, cells were stimulated with G-CSF (100 ng/ ml) for 30 min or left untreated, washed with cold phosphate-buffered saline and resuspended in lysis buffer. See Supplementary Materials and methods for buffer composition and details on immunoprecipitations and Western blotting with anti-FLAG, anti-HA and anti-poly-Ub (FK2, Affiniti Research Products, Exeter, UK) antibodies.
Detection of virus integrations in Wsb-2 To determine orientation and localization of Gr-1.4. MuLV integrations in Wsb-2, a nested PCR was performed on genomic DNA from primary tumors as described (Figure 1a) . For the first PCR, Wsb-2-specific primers a, b, c and d were used in combination with Gr-1.4 long terminal repeat (LTR)-specific primers L1 and L2. For the nested PCR, Wsb-2-specific primers e, f, g and h were used in combination with Gr-1.4 LTR-specific primers L1N and L2N. PCR fragments were analysed as described .
WSB-2 expression in human AML Real-time PCR was performed on complementary DNA from 260 AML patients using an Applied Biosystems 7900 instrument (Applied Biosystems, Weiterstadt, Germany) and SYBR Green PCR Master Mix (Applied Biosystems) Valk et al., 2004) . Primers were WSB-2F6 and WSB-2R6. The porphobilinogen deaminase gene was taken as reference . 
